The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Potassium Phosphates
Potassium Phosphates in sodium chloride · POTASSIUM PHOSPHATE, MONOBASIC 4.48 mg/mL; POTASSIUM PHOSPHATE, DIBASIC 4.72 mg/mL · Injection · Intravenous · Amneal Pharmaceuticals LLC
NDC 70121-1722-09 · 24 POUCH in 1 CARTON / 1 BAG in 1 POUCH / 250 mL in 1 BAG · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$840.00
Reported to Texas DSHS · 2026 annual filing · Amneal Pharmaceuticals LLC
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis · label · manufacture · pack · sterilize
- analysis · label · manufacture · pack · sterilize
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 2 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Xywav and Xyrem
Regulatory
- Application
- NDA218343
- TE code
- —
- Approval date
- Jul 26, 2024
- Patents / exclusivity
- 1 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 11925661 | Oct 12, 2041 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Potassium Phosphates in sodium chloride (Injection)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | POTASSIUM PHOSPHATE, MONOBASIC 4.48 mg/mL; POTASSIUM PHOSPHATE, DIBASIC 4.72 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| Amneal Pharmaceuticals LLC | POTASSIUM PHOSPHATE, MONOBASIC 4.72 mg/mL; POTASSIUM PHOSPHATE, DIBASIC 4.48 mg/mL | Jul 22, 2026 | Aug 19, 2026 |
| Amneal Pharmaceuticals LLC | POTASSIUM PHOSPHATE, DIBASIC 4.72 mg/mL; POTASSIUM PHOSPHATE, MONOBASIC 4.48 mg/mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Potassium Phosphates — NDC 70121-1722-09," retrieved September 3, 2026, https://drugdashboards.com/drug/70121172209.
Free to cite with attribution — see how the data is put together.